Virtus ETF Advisers as of Sept. 30, 2016
Portfolio Holdings for Virtus ETF Advisers
Virtus ETF Advisers holds 154 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Energy Transfer Partners | 7.8 | $16M | 434k | 37.00 | |
| Williams Partners | 7.0 | $14M | 387k | 37.19 | |
| Buckeye Partners | 5.4 | $11M | 156k | 71.60 | |
| Sunoco Logistics Partners | 4.7 | $9.8M | 345k | 28.41 | |
| Energy Transfer Equity (ET) | 4.3 | $9.0M | 533k | 16.79 | |
| Enbridge Energy Partners | 4.3 | $8.8M | 348k | 25.43 | |
| Mplx (MPLX) | 4.2 | $8.7M | 256k | 33.86 | |
| Enterprise Products Partners (EPD) | 3.6 | $7.5M | 270k | 27.63 | |
| Plains All American Pipeline (PAA) | 3.2 | $6.6M | 209k | 31.41 | |
| Oneok Partners | 3.0 | $6.2M | 155k | 39.95 | |
| Magellan Midstream Partners | 2.9 | $5.9M | 84k | 70.74 | |
| Tesoro Logistics Lp us equity | 2.7 | $5.6M | 116k | 48.44 | |
| Enlink Midstream Ptrs | 2.6 | $5.4M | 305k | 17.71 | |
| Eqt Midstream Partners | 2.3 | $4.7M | 62k | 76.19 | |
| Western Gas Partners | 2.0 | $4.2M | 76k | 55.05 | |
| Genesis Energy (GEL) | 1.8 | $3.6M | 96k | 37.97 | |
| Crestwood Equity Partners master ltd part | 1.6 | $3.2M | 151k | 21.25 | |
| iShares S&P NA Tech. Sec. Idx (IGM) | 1.3 | $2.7M | 22k | 123.60 | |
| Phillips 66 Partners | 1.3 | $2.6M | 54k | 48.61 | |
| Ngl Energy Partners Lp Com Uni (NGL) | 1.1 | $2.2M | 117k | 18.84 | |
| Dcp Midstream Partners | 1.1 | $2.2M | 62k | 35.34 | |
| iShares Dow Jones US Energy Sector (IYE) | 1.0 | $2.0M | 52k | 39.00 | |
| Williams Companies (WMB) | 0.9 | $1.9M | 61k | 30.73 | |
| iShares Barclays 20+ Yr Treas.Bond (TLT) | 0.8 | $1.7M | 12k | 137.49 | |
| Tesaro | 0.7 | $1.5M | 15k | 100.22 | |
| TC Pipelines | 0.6 | $1.3M | 23k | 57.04 | |
| WESTERN GAS EQUITY Partners | 0.6 | $1.3M | 31k | 42.49 | |
| ProShares Ultra 20+Year Tsury ETF (UBT) | 0.6 | $1.2M | 13k | 97.10 | |
| Vanguard REIT ETF (VNQ) | 0.6 | $1.2M | 14k | 86.77 | |
| Shell Midstream Prtnrs master ltd part | 0.6 | $1.2M | 38k | 32.08 | |
| Exelixis (EXEL) | 0.5 | $1.1M | 85k | 12.79 | |
| Ariad Pharmaceuticals | 0.5 | $1.0M | 76k | 13.70 | |
| Raptor Pharmaceutical | 0.5 | $1.0M | 114k | 8.97 | |
| Theravance Biopharma (TBPH) | 0.5 | $1.0M | 28k | 36.26 | |
| Ionis Pharmaceuticals (IONS) | 0.5 | $1.0M | 28k | 36.65 | |
| Vanda Pharmaceuticals (VNDA) | 0.5 | $957k | 58k | 16.63 | |
| Seattle Genetics | 0.4 | $865k | 16k | 54.04 | |
| Progenics Pharmaceuticals | 0.4 | $857k | 135k | 6.33 | |
| Halozyme Therapeutics (HALO) | 0.4 | $847k | 70k | 12.08 | |
| Retrophin | 0.4 | $841k | 38k | 22.37 | |
| Spectra Energy | 0.4 | $818k | 19k | 42.73 | |
| Enlink Midstream (ENLC) | 0.4 | $836k | 50k | 16.74 | |
| Biogen Idec (BIIB) | 0.4 | $806k | 2.6k | 313.01 | |
| Sarepta Therapeutics (SRPT) | 0.4 | $795k | 13k | 61.39 | |
| Ironwood Pharmaceuticals (IRWD) | 0.4 | $768k | 48k | 15.88 | |
| Targa Res Corp (TRGP) | 0.4 | $769k | 16k | 49.12 | |
| Incyte Corporation (INCY) | 0.4 | $736k | 7.8k | 94.31 | |
| Intercept Pharmaceuticals In | 0.3 | $721k | 4.4k | 164.69 | |
| BioMarin Pharmaceutical (BMRN) | 0.3 | $711k | 7.7k | 92.57 | |
| Nektar Therapeutics (NKTR) | 0.3 | $711k | 41k | 17.19 | |
| Enanta Pharmaceuticals (ENTA) | 0.3 | $709k | 27k | 26.61 | |
| Regeneron Pharmaceuticals (REGN) | 0.3 | $683k | 1.7k | 402.24 | |
| Amgen (AMGN) | 0.3 | $679k | 4.1k | 166.79 | |
| United Therapeutics Corporation (UTHR) | 0.3 | $685k | 5.8k | 118.02 | |
| PDL BioPharma | 0.3 | $666k | 199k | 3.35 | |
| Medicines Company | 0.3 | $644k | 17k | 37.73 | |
| Celgene Corporation | 0.3 | $644k | 6.2k | 104.51 | |
| Momenta Pharmaceuticals | 0.3 | $644k | 55k | 11.69 | |
| Clovis Oncology | 0.3 | $644k | 18k | 36.05 | |
| Merrimack Pharmaceuticals In | 0.3 | $636k | 100k | 6.35 | |
| Omeros Corporation (OMER) | 0.3 | $624k | 56k | 11.16 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.3 | $594k | 6.8k | 87.17 | |
| Gilead Sciences (GILD) | 0.3 | $589k | 7.5k | 79.06 | |
| Alexion Pharmaceuticals | 0.3 | $581k | 4.7k | 122.44 | |
| Keryx Biopharmaceuticals | 0.3 | $562k | 106k | 5.31 | |
| Arena Pharmaceuticals | 0.3 | $556k | 318k | 1.75 | |
| Ligand Pharmaceuticals In (LGND) | 0.3 | $549k | 5.4k | 102.01 | |
| Array BioPharma | 0.2 | $507k | 75k | 6.75 | |
| Cheniere Energy Partners (CQP) | 0.2 | $515k | 18k | 29.28 | |
| Puma Biotechnology (PBYI) | 0.2 | $514k | 7.7k | 67.05 | |
| Vitae Pharmaceuticals | 0.2 | $512k | 25k | 20.93 | |
| Acorda Therapeutics | 0.2 | $505k | 24k | 20.89 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $505k | 16k | 31.81 | |
| Ptc Therapeutics I (PTCT) | 0.2 | $488k | 35k | 14.00 | |
| Vaneck Vectors Gold Miners mutual (GDX) | 0.2 | $487k | 18k | 26.42 | |
| Agenus | 0.2 | $454k | 63k | 7.18 | |
| Xencor (XNCR) | 0.2 | $432k | 18k | 24.48 | |
| Bluebird Bio (BLUE) | 0.2 | $418k | 6.2k | 67.80 | |
| Sage Therapeutics (SAGE) | 0.2 | $404k | 8.8k | 46.05 | |
| Bellicum Pharma | 0.2 | $404k | 20k | 19.90 | |
| Blueprint Medicines (BPMC) | 0.2 | $387k | 13k | 29.66 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $374k | 85k | 4.40 | |
| Newlink Genetics Corporation | 0.2 | $367k | 25k | 15.00 | |
| Synergy Pharmaceuticals | 0.2 | $376k | 68k | 5.51 | |
| Radius Health | 0.2 | $378k | 7.0k | 54.11 | |
| Insmed (INSM) | 0.2 | $356k | 25k | 14.51 | |
| Minerva Neurosciences | 0.2 | $362k | 26k | 14.12 | |
| Boardwalk Pipeline Partners | 0.2 | $324k | 19k | 17.17 | |
| Cempra | 0.2 | $321k | 13k | 24.16 | |
| Prothena (PRTA) | 0.2 | $330k | 5.5k | 59.90 | |
| Advaxis | 0.2 | $330k | 31k | 10.68 | |
| La Jolla Pharmaceuticl Com Par | 0.2 | $340k | 14k | 23.79 | |
| Amicus Therapeutics (FOLD) | 0.1 | $301k | 41k | 7.39 | |
| Sorrento Therapeutics (SRNE) | 0.1 | $313k | 40k | 7.74 | |
| Five Prime Therapeutics | 0.1 | $306k | 5.8k | 52.42 | |
| Fibrogen (FGEN) | 0.1 | $308k | 15k | 20.72 | |
| Spark Therapeutics | 0.1 | $317k | 5.3k | 60.03 | |
| Lexicon Pharmaceuticals (LXRX) | 0.1 | $319k | 18k | 18.07 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $318k | 43k | 7.35 | |
| Macrogenics (MGNX) | 0.1 | $292k | 9.8k | 29.91 | |
| Karyopharm Therapeutics (KPTI) | 0.1 | $298k | 31k | 9.73 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $287k | 4.1k | 70.86 | |
| Ignyta | 0.1 | $281k | 45k | 6.30 | |
| Alder Biopharmaceuticals | 0.1 | $281k | 8.6k | 32.74 | |
| Nantkwest | 0.1 | $295k | 38k | 7.78 | |
| Aimmune Therapeutics | 0.1 | $293k | 20k | 15.02 | |
| Neurocrine Biosciences (NBIX) | 0.1 | $270k | 5.3k | 50.71 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $276k | 4.1k | 67.68 | |
| Immunomedics | 0.1 | $263k | 81k | 3.25 | |
| Tg Therapeutics (TGTX) | 0.1 | $273k | 35k | 7.73 | |
| Cytokinetics (CYTK) | 0.1 | $270k | 29k | 9.19 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $268k | 5.1k | 52.88 | |
| Trevena | 0.1 | $259k | 38k | 6.75 | |
| Akebia Therapeutics (AKBA) | 0.1 | $268k | 30k | 9.06 | |
| Lion Biotechnologies | 0.1 | $269k | 33k | 8.22 | |
| Kite Pharma | 0.1 | $273k | 4.9k | 55.84 | |
| Loxo Oncology | 0.1 | $268k | 10k | 26.19 | |
| Atara Biotherapeutics | 0.1 | $271k | 13k | 21.42 | |
| Aduro Biotech | 0.1 | $261k | 21k | 12.42 | |
| Axovant Sciences | 0.1 | $267k | 19k | 14.00 | |
| Global Blood Therapeutics In | 0.1 | $270k | 12k | 23.06 | |
| Spdr S&p 500 Etf Tr option | 0.1 | $250k | 200.00 | 1250.00 | |
| Celldex Therapeutics | 0.1 | $241k | 60k | 4.05 | |
| Acceleron Pharma | 0.1 | $250k | 6.9k | 36.18 | |
| Avexis | 0.1 | $242k | 5.9k | 41.23 | |
| Beigene (BGNE) | 0.1 | $257k | 8.3k | 30.80 | |
| Toronto Dominion Bk Ont note 3.625% 9/1 | 0.1 | $245k | 245k | 1.00 | |
| NuStar Energy | 0.1 | $228k | 4.6k | 49.48 | |
| Achillion Pharmaceuticals | 0.1 | $218k | 27k | 8.10 | |
| ZIOPHARM Oncology | 0.1 | $226k | 40k | 5.63 | |
| Portola Pharmaceuticals | 0.1 | $221k | 9.7k | 22.70 | |
| Oncomed Pharmaceuticals | 0.1 | $232k | 20k | 11.45 | |
| Inovio Pharmaceuticals | 0.1 | $224k | 24k | 9.31 | |
| Geron Corporation (GERN) | 0.1 | $208k | 92k | 2.26 | |
| Epizyme | 0.1 | $214k | 22k | 9.84 | |
| Esperion Therapeutics (ESPR) | 0.1 | $215k | 16k | 13.84 | |
| Ophthotech | 0.1 | $217k | 4.7k | 46.15 | |
| Concert Pharmaceuticals I equity | 0.1 | $212k | 21k | 10.12 | |
| Uniqure Nv (QURE) | 0.1 | $203k | 27k | 7.66 | |
| Spectra Energy Partners | 0.1 | $184k | 4.2k | 43.76 | |
| Sangamo Biosciences (SGMO) | 0.1 | $191k | 41k | 4.63 | |
| ImmunoGen | 0.1 | $190k | 71k | 2.68 | |
| Oneok (OKE) | 0.1 | $185k | 3.6k | 51.52 | |
| iShares Dow Jones US Financial (IYF) | 0.1 | $179k | 2.0k | 90.13 | |
| Dynavax Technologies (DVAX) | 0.1 | $181k | 17k | 10.46 | |
| Juno Therapeutics | 0.1 | $181k | 6.0k | 30.08 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $190k | 27k | 7.04 | |
| Applied Genetic Technol Corp C | 0.1 | $159k | 16k | 9.80 | |
| iShares Dow Jones US Utilities (IDU) | 0.1 | $154k | 1.3k | 122.81 | |
| Regulus Therapeutics | 0.1 | $153k | 46k | 3.31 | |
| Intra Cellular Therapies (ITCI) | 0.1 | $98k | 6.4k | 15.21 | |
| Seres Therapeutics (MCRB) | 0.1 | $100k | 8.1k | 12.35 | |
| Novavax | 0.0 | $78k | 38k | 2.08 | |
| Williams Cos Inc Del option | 0.0 | $54k | 350.00 | 154.29 |
